Remarkably, after treatment with an anti-PD-1 antibody, the replication of the CP BVDV (p < 0.01, Figure 13A) and NCP BVDV (p < 0.05, Figure 13C) were significantly inhibited at day 7 of post-infection in blood. The gene discussed is RPL17; the disease is infection.